## Biggest Flaw

The biggest flaw is that the process optimizes for “collecting expert advice” rather than producing a **traceable decision-and-change system**. If each iteration yields only consensus/disagreement/open questions, you risk accumulating smart commentary without a rigorous mechanism for deciding:

- what changes AGI.md should actually receive,
- why each change was accepted/rejected,
- which risks remain unresolved,
- which claims need evidence or tests,
- whether later iterations are improving or merely rephrasing.

You need an explicit **issue/decision ledger** tied to document sections and proposed patches.

## Q1-Q7 Answers

### 1. Is the methodology sound? Biggest flaw?

Mostly sound: multi-model, multi-pass, angle variation, and synthesis are good. But the main weakness is lack of **traceability from critique → decision → document change → validation**. Without this, iteration 7 may produce a beautiful synthesis but not a defensible spec.

### 2. Preserve raw responses or trust synthesis?

Do **not** include full raw responses in every prompt. Too noisy, too expensive, and likely to anchor future models on irrelevant phrasing.

But do not fully trust synthesis either. Use:

- synthesis,
- short attributed excerpts for key disagreements,
- issue IDs pointing to raw source,
- a “minority report” section preserving high-value dissent.

The goal is not raw preservation; it is **provenance-preserving compression**.

### 3. Different angles or same angle with progressive depth?

Use different angles, but with a recurring invariant checklist every round.

Example:

- Each iteration has a special focus.
- Every iteration must also score: coherence, implementability, novelty, falsifiability, missing definitions, internal contradictions, security/failure modes.

Angle variation prevents local overfitting. The invariant checklist prevents drift.

### 4. Pair disagreeing models in iteration 2?

Do both, sequentially.

First: keep all 14 independent to preserve diversity.

Then: run targeted adversarial pairings only on high-value disagreements, e.g.:

- “Model A argues X, Model B argues Y. Steelman both, then adjudicate.”
- “What empirical/design test would distinguish these positions?”

Do not make the whole process debate-based; debates can reward rhetoric. Use debate only for unresolved pivotal splits.

### 5. Skip cheap models in deep iterations?

Do not use all 14 uniformly every time.

Recommended:

- Iter 1: all 14 for breadth.
- Iter 2-5: top 7 plus 2-3 rotating outsiders/cheap models for diversity.
- Iter 6-7: strongest 5-7, plus one contrarian model deliberately prompted to attack consensus.

Cheap/weaker models can still surface useful anomalies. But deep refinement should favor models with high reasoning density.

### 6. Synthesizer bias: fatal conflict?

Not fatal, but real.

Mitigations:

- Use a fixed synthesis schema.
- Maintain model-attributed claims.
- Have at least one non-Claude model audit the synthesis each round.
- Include “what the synthesizer may have underweighted.”
- Keep raw responses accessible.
- Use an issue ledger where every accepted/rejected point has rationale.

Also, final synthesis by Claude is acceptable only if preceded by an independent audit pass.

### 7. One addition to push from 8/10 to 10/10?

Add a **living issue/decision/change ledger**.

Each entry:

- Issue ID
- AGI.md section/line reference
- Source models
- Claim/critique
- Agreement level
- Severity
- Proposed document patch
- Accepted/rejected/deferred
- Rationale
- Validation needed
- Open risks

This becomes the spine of the whole process.

## Methodology Improvement

Require every model response to output in a structured format:

1. top 5 critical issues,
2. proposed patch or rewrite,
3. confidence,
4. affected sections,
5. hidden assumptions,
6. strongest objection to its own recommendation,
7. tests/falsifiers.

Then synthesize into the ledger. This converts opinions into actionable spec engineering.

## My Rating: 8/10

Strong architecture, good use of diversity, reasonable compression strategy. It becomes 10/10 only when transformed from “iterative consultation” into a **provenance-tracked specification refinement pipeline**.